Cargando…
Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells
BACKGROUND/AIMS: Transforming growth factor-β1 (TGF-β1) induction of epithelial-mesenchymal transition (EMT) is one of the mechanisms by which colorectal cancer (CRC) cells acquire migratory and invasive capacities, and subsequently metastasize. Parthenolide (PT) expresses multiple anti-cancer and a...
Autores principales: | Zhu, Shi Mao, Park, Yong Ran, Seo, Seung Yong, Kim, In Hee, Lee, Soo Teik, Kim, Sang Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821947/ https://www.ncbi.nlm.nih.gov/pubmed/31426622 http://dx.doi.org/10.5217/ir.2019.00031 |
Ejemplares similares
-
Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells
por: Kim, Hyun-Young, et al.
Publicado: (2015) -
Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells
por: Liu, Yu Chuan, et al.
Publicado: (2017) -
Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model
por: Kim, In Hee, et al.
Publicado: (2012) -
Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway
por: Trang, Kieu Thi Thu, et al.
Publicado: (2014) -
Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer
por: Kim, Se‐Lim, et al.
Publicado: (2017)